Pharma Focus Asia

Repligen

LATEST NEWSRead more...

13

Jun 2024

Innovent Secures Fast Track Status from the FDA for IBI343, a Monotherapy for Advanced Pancreatic Cancer

Innovent Biologics Inc a global leader in biopharmaceuticals focuses on the development manufacturing and commercialization of highquality medicines for various major diseases including oncology

13

Jun 2024

IQVIA Introduces "One Home" Platform to Simplify Clinical Trials and Reduce Site Burden

IQVIA has introduced One Home for Sites a novel technology platform aimed at simplifying clinical trial management This platform provides a unified signon and dashboard integrating various

13

Jun 2024

NSG BioLabs and Eppendorf Group Form Alliance to Enhance Biotech Support in Singapore

NSG BioLabs Singapores largest provider of biotech coworking laboratory and office space has announced a partnership with Eppendorf a prominent global life science company This partnership

12

Jun 2024

DoH and Penn Medicine to Expand Partnership in Translational Research, Opening Additional Labs in Abu Dhabi

The Department of Health Abu Dhabi the regulatory body for healthcare has entered into a second Memorandum of Understanding with the Perelman School of Medicine at the University of Pennsylvania

12

Jun 2024

Asgard Therapeutics Collaborates With Exothera to Advance AT-108 Into Clinical Trials

Asgard Therapeutics a private biotech company focused on in vivo direct cell reprogramming for cancer immunotherapy has chosen Exothera SA to develop the manufacturing processes

11

Jun 2024

Zymeworks Announces NMPA Acceptance of Zanidatamab Biologics License Application for Second-Line Treatment of Biliary Tract Cancer in China

Zymeworks Inc a clinicalstage biotechnology firm focused on developing innovative biotherapeutics announced that the Center for Drug Evaluation of the National Medical Products Administration in China

Solovpe

press releasesRead more...

13

Jun 2024

GSK Enters Into A Multi-Year Data Licence Agreement With Ochre Bio To Further Investigate The Drivers Of Liver Disease

Ochre Bio a pioneer in chronic liver disease medicine development has today announced the start of a multiyear data licence agreement with GSK The partnership will provide GSK with access to Ochre Bios

13

Jun 2024

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

Belite Bio Inc a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs

13

Jun 2024

Sibylla Biotech and MD Anderson Announce Strategic Collaboration to Discover and Develop Small-Molecule Protein Degraders

Sibylla Biotech and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration agreement to discover and develop novel smallmolecule cancer therapies

13

Jun 2024

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy

OBI Pharma a clinicalstage oncology company today announced the initiation of a Phase clinical trial of OBI an antibodydrug conjugate targeting TROP

12

Jun 2024

NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application

NurExone Biologic Inc a pioneering biopharmaceutical company developing regenerative medicine therapies is pleased to announce that the Japan

12

Jun 2024

Lokavant Launches First AI Clinical Trial Feasibility Solution to Optimize Trials From Strategic Planning to Mid-Study Re-forecasting

Lokavant the clinical trial intelligence platform company today announced Spectrum the first AI clinical trial feasibility software solution for trial optimization across the entire clinical development value chain

12 - 14

Jun 2024

18 - 19

Jun 2024

18 - 19

Jun 2024

18 - 20

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

19 - 21

Jun 2024

CPHI & PMEC 2024

Shanghai, China

19 - 20

Jun 2024

LogiPharma Asia 2024

Equarius Hotel, Singapore

20 - 22

Jun 2024
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI China || PMEC China 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    Kinase Inhibitors as Antiviral Agents

    Thanigaimalai Pillaiyar

    Junior Research Group Leader, Pharmaceutical/Medicinal Chemistry, Tuebingen University

    Stefan Laufer

    Professor, Pharmaceutical/Medicinal Chemistry, Tuebingen University

  • 3

    Incipient Biopharmaceutical Claims of Milk Derived Exosomes

    Rakesh Kumar Tekade

    Associate Professor, NIPER-Ahmedabad

    Nupur Vasdev

    Pursuing PhD in Pharmaceutics, NIPER-Ahmedabad

    Manisha Choudhary

    Pursuing M.S. (Pharm) in Pharmaceutics, NIPER-Ahmedabad

    Suryanarayana Polaka

    Pursuing PhD, NIPER-Ahmedabad

    Kiran Kalia

    Director and Professor, NIPER-Ahmedabad

  • 4

    Combating the FWA Menace

    Ravi Iyer

    Senior Director - IT, Elevance Health

    Narasimha Nalamalapu

    Solutions Architect, Tetrasoft Inc

  • 5

    Machine Learning for New Drugs

    Sneha Rai

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology.

    Venugopal Bhatia

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology

    Sonika Bhatnagar

    Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology

KNOWLEDGE BANK

  • Interviews

    GE Healthcare

    President & CEO

    Our current business focus and strengths are in the areas of bioprocessing proteins cellular analysis cell handling and tools for cell therapy Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provideWe are particularly excited about the sample collection and storage opportunity with the FTA product lineWe have a stron...
  • Articles

    Homeopathic Science

    Homeopathy a controversial medical system discovered by a German physician Samuel Hahnemann was first postulated at the end of the th century and mentioned in the first edition of his Organon in In such anecdotal times where theories about the deficiency four bodily fluids theories about corrupted juices were propagating against all odds the beginning of prescientific medical theories were bo...

  • White Papers

    Meeting Current and Future Serialisation Challenges: An AESICA White Paper

    SummarySerialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another Several countries including China South Korea Turkey Argentina and Brazil already have regulations in place that must be complied with whilst many others including countries i

EDITORIAL SECTION